Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Analysts Are Reducing Their Forecasts For This Year [Yahoo! Finance]
Fennec Pharmaceuticals Inc. (FENC)
Last fennec pharmaceuticals inc. earnings: 11/12 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investors.fennecpharma.com/investor-relations
Company Research
Source: Yahoo! Finance
revision to their near-term (statutory) forecasts for the organization. Both revenue and earnings per share (EPS) forecasts went under the knife, suggesting analysts have soured majorly on the business. Following the downgrade, the most recent consensus for Fennec Pharmaceuticals from its six analysts is for revenues of US$54m in 2024 which, if met, would be a decent 11% increase on its sales over the past 12 months. Per-share earnings are expected to surge 100% to US$0.20. Previously, the analysts had been modelling revenues of US$63m and earnings per share (EPS) of US$0.51 in 2024. It looks like analyst sentiment has declined substantially, with a measurable cut to revenue estimates and a large cut to earnings per share numbers as well. Check out our latest analysis for Fennec Pharmaceuticals It'll come as no surprise then, to learn that the analysts have cut their price target 5.9% to US$15.83. Taking a look at the bigger picture now, one of the ways we can understand these
Show less
Read more
Impact Snapshot
Event Time:
FENC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FENC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FENC alerts
High impacting Fennec Pharmaceuticals Inc. news events
Weekly update
A roundup of the hottest topics
FENC
News
- The past three years for Fennec Pharmaceuticals (NASDAQ:FENC) investors has not been profitable [Yahoo! Finance]Yahoo! Finance
- Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences [Financial Post (Toronto, Ontario, Canada)]Financial Post
- Fennec Pharmaceuticals to Participate in Upcoming Investor Conferences [Yahoo! Finance]Yahoo! Finance
- Fennec Pharmaceuticals to Participate in Upcoming Investor ConferencesGlobeNewswire
- Fennec Pharmaceuticals Inc (NASDAQ: FENC) had its price target lowered by analysts at HC Wainwright from $15.00 to $13.00. They now have a "buy" rating on the stock.MarketBeat
FENC
Earnings
- 8/13/24 - Miss
FENC
Sec Filings
- 10/1/24 - Form 4
- 10/1/24 - Form 4
- 10/1/24 - Form 144
- FENC's page on the SEC website